| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2010691 | Pharmacological Reports | 2016 | 6 Pages |
Abstract
Patients with TSC have disrupted lipid homeostasis before and during treatment with everolimus, which might be partially connected to the mTOR-dependent nutritional status of the patients. There is a need to develop strategies for children with TSC treated with everolimus, who experience hyperlipidemia.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Joanna TreliÅska, Iwona Dachowska, Katarzyna Kotulska, Sergiusz Jóźwiak, Wojciech Fendler, Wojciech MÅynarski,